Phase 3 HIV-1 Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC570 enrolled47 locationsNCT07266831
Recruiting
Phase 2Phase 3
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
HIV-1-infection
Gilead Sciences75 enrolled21 locationsNCT06532656
Recruiting
Phase 3
DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection
HIV-1-infection
ANRS, Emerging Infectious Diseases610 enrolled19 locationsNCT06203132
Recruiting
Phase 3
Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
HIV-1-infection
University of Nairobi392 enrolled9 locationsNCT06747507
Recruiting
Phase 3
Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
HIV-1-infectionNon-Adherence, Medication
Chang Gung Memorial Hospital40 enrolled4 locationsNCT06507059
Recruiting
Phase 3
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
HIV-1-infection
Chelsea and Westminster NHS Foundation Trust150 enrolled3 locationsNCT04892654